You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 4, July 26, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reducing the Impact of Opportunistic Infections in Patients With HIV Infection

New Guidelines

Jonathan E. Kaplan, MD; Henry Masur, MD; Harold W. Jaffe, MD; King K. Holmes, MD, PhD

JAMA. 1995;274(4):347-348.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

As many as 1 million individuals in the United States are infected with the human immunodeficiency virus (HIV).1 For these persons, and especially for the approximately 250 000 who have severe immunosuppression as measured by a CD4+ lymphocyte count below 0.20x109/L (200/µL) (includes persons with [T. Green, PhD, Centers for Disease Control and Prevention (CDC), unpublished results, 1994] and without2 AIDS-defining illnesses) opportunistic infections exact a heavy toll in terms of quality and length of life. Among patients with severe immunosuppression, the cumulative risk of serious opportunistic infection has been estimated to be 33% after 1 year and 58% after 2 years.3 In addition to the morbidity and mortality associated with these opportunistic infections, treatment of these illnesses costs billions of dollars annually.

The last 5 years have witnessed a gratifying surge in our knowledge of the environmental sources of opportunistic pathogens, ways to reduce . . . [Full Text PDF of this Article]


Author Affiliations

From the National Center for Infectious Diseases (Drs Kaplan and Jaffe) and the National Center for Prevention Services (Dr Kaplan), Centers for Disease Control and Prevention, Atlanta, Ga; the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md (Dr Masur); and the Center for AIDS and STDs, University of Washington, Seattle (Dr Holmes).


Footnotes

Reprint requests to Division of HIV/AIDS Prevention, Mailstop G-29, Centers for Disease Control and Prevention, Atlanta, GA 30333 (Dr Kaplan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.